Literature DB >> 22924636

Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.

Andrés J M Ferreri, Marta Bruno Ventre, Giovanni Donadoni, Chiara Cattaneo, Luca Fumagalli, Marco Foppoli, Silvia Mappa, Silvia Govi, Massimo Di Nicola, Giuseppe Rossi, Umberto Tirelli, Federico Caligaris-Cappio, Michele Spina, Alessandro Re.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22924636     DOI： 10.1111/bjh.12020

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.

Authors:  S K Barta; M S Samuel; X Xue; D Wang; J Y Lee; N Mounier; J-M Ribera; M Spina; U Tirelli; R Weiss; L Galicier; F Boue; R F Little; K Dunleavy; W H Wilson; C Wyen; S C Remick; L D Kaplan; L Ratner; A Noy; J A Sparano
Journal:  Ann Oncol       Date:  2015-01-28       Impact factor: 32.976

Review 2.  Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Roni Tamari; Jeannette Y Lee; Nicolas Mounier; Lawrence D Kaplan; Josep-Maria Ribera; Michele Spina; Umberto Tirelli; Rudolf Weiss; Lionel Galicier; Francois Boue; Wyndham H Wilson; Christoph Wyen; Albert Oriol; José-Tomás Navarro; Kieron Dunleavy; Richard F Little; Lee Ratner; Olga Garcia; Mireia Morgades; Scot C Remick; Ariela Noy; Joseph A Sparano
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

3.  Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.

Authors:  Carlyn Rose C Tan; Stefan K Barta; Jeannette Lee; Michelle A Rudek; Joseph A Sparano; Ariela Noy
Journal:  Leuk Lymphoma       Date:  2017-11-21

4.  Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.

Authors:  Domenico Albano; Giovanni Bosio; Chiara Pagani; Alessandro Re; Alessandra Tucci; Raffaele Giubbini; Francesco Bertagna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-02       Impact factor: 9.236

5.  Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.

Authors:  David A Rizzieri; Jeffrey L Johnson; John C Byrd; Gerard Lozanski; Kristie A Blum; Bayard L Powell; Thomas C Shea; Sreenivasa Nattam; Eva Hoke; Bruce D Cheson; Richard A Larson
Journal:  Br J Haematol       Date:  2014-01-15       Impact factor: 6.998

6.  Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.

Authors:  Polina Shindiapina; Maciej Pietrzak; Michal Seweryn; Eric McLaughlin; Xiaoli Zhang; Mat Makowski; Elshafa Hassan Ahmed; Sarah Schlotter; Rebecca Pearson; Rhonda Kitzler; Anna Mozhenkova; Jennifer Le-Rademacher; Richard F Little; Gorgun Akpek; Ernesto Ayala; Steven M Devine; Lawrence D Kaplan; Ariela Noy; Uday R Popat; Jack W Hsu; Lawrence E Morris; Adam M Mendizabal; Amrita Krishnan; William Wachsman; Nita Williams; Nidhi Sharma; Craig C Hofmeister; Stephen J Forman; Willis H Navarro; Joseph C Alvarnas; Richard F Ambinder; Gerard Lozanski; Robert A Baiocchi
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

7.  Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane.

Authors:  Kashif Jilani; Florian Lang
Journal:  Toxins (Basel)       Date:  2013-04-19       Impact factor: 4.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.